1M Hepes/NaOH (pH 7.4) containing 1.4M NaCl and 25mM CaCl2 (“binding buffer”). Volumes of 100μL of the cell suspensions were transferred to 1.5mL Eppendorf tubes. Solutions of 5μL of AnnexinV-PE and 5μL of 7-ADD were added to the suspensions, followed by vortexing and incubation for 15min at room Bleomycin in vitro temperature in the dark. Then, 400μL “binding buffer” were added to each tube containing the incubated suspension, followed by analysis Inhibitors,research,lifescience,medical with a flow cytometer. 2.5. Caspase-3 Assay Caspase-3 activity was evaluated

spectrophotometrically at λ = 405nm with the caspase-3 substrate Ac-DEVD-pNA. OST cells were suspended at 2.0 × 105cells/mL in D-MEM with 10% FBS and then pipetted into 6-well culture plates. After 16 hours of incubation at 37°C and 5% CO2, the medium in each plate was exchanged by 10% FBS, D-MEM containing either 50μg/mL Inhibitors,research,lifescience,medical ESA, or 50μg/mL ESA + ZVAD-FMK (=N-Benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl ketone) which is a known caspase-3 inhibitor, or PBS as control. Following

culturing for 16 hours, the caspase-3 activity in these kinds of cells was measured Inhibitors,research,lifescience,medical with the caspase assay system (Promega, Madison, WI, USA), using a spectrophotometer U-2000 (HITACHI, Tokyo, Japan) according to the manufacturer’s instructions. 2.6. Test of ESA Binding to the Cells An amount of 1.22mg/mL ESA was fluorescently labeled by addition of 1mg/mL Rhodamine 6G (Rh6G) in 0.15M sodium carbonate buffer (pH = 9.0), followed by removal of free FITC by using a PD-10 column (GE Healthcare, CT, USA). OST cells and LM8 cells, suspended at a concentration of 2.0 × 105cells/mL, were cultured in 10% FBS ERDF medium. After 16 hours, the culture medium was exchanged with a culture medium containing 10% FITC-ESA solution, both types of cells were separately

incubated Inhibitors,research,lifescience,medical for 3, 6, 9, 12, and 24 hours in Inhibitors,research,lifescience,medical a CO2 incubator at 37°C, respectively. After the incubation, both cells were washed with cold PBS twice. Both cell suspensions were then analyzed by flow cytometry using a FACS Calibur instrument (Becton Dickinson, Mansfield, MA, USA). In a similar way, the binding activities of ESA (labeled with either rhodamine 6G (Rh6G) or FITC) to the sugar chains on the surface of OST cells were examined by incubation with α-mannnosidase, or β-mannnosidase, or endoglycosidase H for 2 hours before adding fluorescenctly mafosfamide labeled ESA. After incubation for 1 hour, the ESA binding to the OST cells was evaluated by using a fluorescence microscope (BH2-RFC, Olympus Corp, Tokyo, Japan) and the flow cytometer. 2.7. Preparation of a Lipidic ESA-Conjugate ESA-SuPE, a phospholipid-ESA conjugate, was prepared as follows: 100μL of a SuPE solution (1.25mg/mL in chloroform) were added to a test tube. A thin film of SuPE formed after evaporation of chloroform under a stream of nitrogen gas. Afterwards, 2.5mL of an ESA solution (0.675mg/mL) were added to the film to react with SuPE in 0.15M sodium carbonate buffer (pH 9.